Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis

Ticker
UPB

Price
31.79
Stock movement up
+0.20 (0.63%)
Company name
Upstream Bio, Inc.
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
1.72B
Ent value
1.66B
Price/Sales
613.75
Price/Book
4.54
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return (CAGR)
194.08%
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Last updated: 2026-01-22

iO Charts is a Seeking Alpha partner

DIVIDENDS

UPB does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales613.75
Price to Book4.54
EV to Sales592.47

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count54.04M
EPS (TTM)-2.27
FCF per share (TTM)-2.27

Income statement

Loading...
Income statement data
Revenue (TTM)2.80M
Gross profit (TTM)2.77M
Operating income (TTM)-140.51M
Net income (TTM)-122.23M
EPS (TTM)-2.27
EPS (1y forward)-3.21

Margins

Loading...
Margins data
Gross margin (TTM)98.89%
Operating margin (TTM)-5020.08%
Profit margin (TTM)-4366.77%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash72.16M
Net receivables683.00K
Total current assets389.02M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment2.27M
Total assets391.19M
Accounts payable3.95M
Short/Current long term debt1.42M
Total current liabilities11.91M
Total liabilities12.61M
Shareholder's equity378.58M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-122.26M
Capital expenditures (TTM)279.00K
Free cash flow (TTM)-122.53M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-32.28%
Return on Assets-31.24%
Return on Invested Capital-32.22%
Cash Return on Invested Capital-32.31%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open31.74
Daily high32.52
Daily low31.70
Daily Volume397K
All-time high32.60
1y analyst estimate49.75
Beta-
EPS (TTM)-2.27
Dividend per share0.00
Ex-div date-
Next earnings date11 Mar 2026

Downside potential

Loading...
Downside potential data
UPBS&P500
Current price drop from All-time high-2.48%-0.89%
Highest price drop-77.84%-19.00%
Date of highest drop8 Apr 20258 Apr 2025
Avg drop from high-39.03%-2.49%
Avg time to new high23 days6 days
Max time to new high264 days89 days

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
UPB (Upstream Bio, Inc.) company logo
Marketcap
1.72B
Marketcap category
Small-cap
Description
Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 clinical development for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps, and in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headquartered in Waltham, Massachusetts.
Employees
52
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...